Intravascular Catheters Global Market Report 2024

An intravascular catheter is a device usually consisting of a hollow fiber through which blood flows, and an immunoisolating membrane that separates transplanted cells from the blood. These catheters are employed for the administration of fluids, medication, blood products, and nutrition, typically inserted into a large vein in the arm or chest.

The main products in the intravascular catheter category include short peripheral intravenous catheters (PIVC) and integrated/closed PIVC. Short PIVCs are those that are less than or equal to 3 inches in length and are commonly used for intravenous medication administration, predominantly in general wards. The various applications of intravascular catheters encompass oncology, gastroenterology, renal disease, infectious diseases, and others, with end-users including hospitals, clinics, ambulatory surgical centers, and homecare.

The intravascular catheters market research report is one of a series of new reports that provides intravascular catheters market statistics, including intravascular catheters industry, global intravascular catheters market size, regional shares, competitors with an intravascular catheters market share, detailed intravascular catheters market segments, market trends and opportunities, and any further data you may need to thrive in the intravascular catheters industry. This intravascular catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The intravascular catheters market size has grown rapidly in recent years. It will grow from $6.76 billion in 2023 to $7.7 billion in 2024 at a compound annual growth rate (CAGR) of 13.8%. The growth observed in the historical period can be attributed to factors such as an increased aging population, a rise in cardiovascular diseases, the adoption of minimally invasive procedures, the digitization of healthcare, and global health initiatives.

The intravascular catheters market size is expected to see rapid growth in the next few years. It will grow to $12.37 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The projected growth in the forecast period can be linked to the expansion of precision medicine, the promotion of sustainable healthcare, the growth of telemedicine, increased focus on patient education and engagement, and the rising utilization of intravascular catheters. Key trends expected in the forecast period involve the development of smart catheters, the implementation of advanced navigation systems, advancements in vascular access for pediatrics, the integration of artificial intelligence (AI) in catheter placement, and progress in non-invasive catheter procedures.

The growth of the intravascular catheters market is being propelled by the increasing hospitalization rate attributed to the high prevalence of chronic diseases. Globally, the prevalence of chronic illnesses is on the rise, leading to a heightened demand for intravascular catheters. These catheters play a crucial role in obtaining samples for tests and facilitating the intake of fluids, nutrients, and blood during the treatment of chronic diseases. Fresenius Medical Care, a German healthcare company, estimates that the number of individuals suffering from chronic kidney failure is expected to increase from 3.7 million patients in 2021 to 4.9 million by 2025. Consequently, the escalating hospitalization rate due to the prevalence of chronic diseases is anticipated to drive the growth of the intravascular catheters market in the years to come.

The growth of the intravascular catheters market is expected to be fueled by the increasing demand for long-term care. Long-term care (LTC) involves providing services and support over an extended period to individuals facing challenges in performing daily activities due to chronic illness, disability, or other conditions. Many individuals requiring long-term care have chronic conditions like diabetes, heart disease, or infections that necessitate ongoing medication regimens. Intravascular catheters, including central venous catheters (CVCs) or peripherally inserted central catheters (PICCs), enable healthcare providers to administer medications directly into the bloodstream, ensuring precise dosing and reducing the need for frequent injections. In 2021–2022, the National Health Service in the UK recorded that 8 out of every 1,000 people aged 18–64 received long-term support. Thus, the increasing demand for long-term care is a significant driver behind the growth of the intravascular catheters market.

A notable trend in the intravascular catheters market is the emphasis on product innovations by major industry players. Companies are actively focusing on introducing new products with advanced features to enhance their market position. For example, B. Braun Medical Inc., a German-based medical and pharmaceutical device manufacturing company, introduced the Introcan Safety 2 IV Catheter in July 2022. This catheter incorporates one-time blood control, enhancing safety for clinicians by reducing the risk of blood exposure and needle stick accidents. Another instance is the introduction of the Shockwave M5+ catheter by Shockwave Medical Inc. in March 2022. This catheter is specifically designed to treat calcified lesions in various arteries, addressing challenges in treatment.

Major companies in the intravascular catheters market are leveraging new technologies, such as AI-enabled intravascular ultrasound, to enhance profitability. AI-enabled intravascular ultrasound (IVUS) integrates artificial intelligence with conventional IVUS imaging to provide more precise and comprehensive information about a patient's blood vessels. Evident Vascular Inc., a US-based ultrasound technology company, launched AI-enabled intravascular ultrasound in October 2023. The Evident Vascular Guidance System, powered by artificial intelligence, improves imaging quality, enabling healthcare professionals to obtain more accurate pictures of blood artery interiors. AI-enabled IVUS technology aids in the identification and treatment of venous and arterial illnesses, thereby improving patient outcomes.

In January 2021, Prunus Technology Co., Ltd., a Shenzhen-based developer and manufacturer of various medical equipment, acquired Biosensors International Group, Ltd. This acquisition allowed Prunus Technology to expand its portfolio into central venous catheters, pressure transducers, pulmonary artery catheters, pacing catheters, thrombolysis catheters, urinary catheters, and other medical consumables. Biosensors International Group, Ltd., based in Singapore, specializes in the critical care consumables business.

Major companies operating in the intravascular catheters market include Cook Group Incorporated, Smiths Medical Inc., Edwards Lifesciences Corporation, Medtronic Inc., Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Cordis Corporation, Koninklijke Philips NV, Terumo Corporation, ACIST Medical Systems Inc., B. Braun Melsungen AG, Teleflex Incorporated, Hollister Incorporated, Coloplast Corp., ConvaTec Inc., Merit Medical Systems Inc., ICU Medical Inc., AngioDynamics Inc., Vygon SA, Becton, Dickinson and Company, C. R. Bard Inc., Teleflex Medical OEM, Nipro Medical Corporation, Argon Medical Devices Inc., Vascular Solutions Inc., Infus Medical (India) Pvt. Ltd., Angiplast Pvt. Ltd., Romsons Scientific & Surgical Pvt. Ltd., Hindustan Syringes & Medical Devices Ltd.

North America was the largest region in the intravascular catheters market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravascular catheters market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the intravascular catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The intravascular catheters market consists of sales of pulmonary artery catheters and pacing wires. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.